GuzeSB. Why psychiatry is a branch of medicine. New York (NY): Oxford University Press; 1992.
2.
FinkMTaylorMA. The medical evidence-based model for psychiatric syndromes: Return to a classical paradigm. Acta Psychiatr Scand. 2008;117(2):81–84.
3.
ParkerGHadzi-PavlovicD, editors. Melancholia: A disorder of movement and mood: A phenomenological and neurobiological review. Cambridge (GB): Cambridge University Press; 1996.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington (DC): APA; 2000. p 417.
6.
FinkMTaylorMA. Catatonia in psychiatric classification: A home of its own. Am J Psychiatry. 2003;160:1223–1241.
7.
WestEDDallyPJ. Effects of iproniazid in depressive syndromes. Br Med J. 1959;1(5136):1491–1494.
8.
CobbSCohenME. Experimental production during rebreathing of sighing respiration and symptoms resembling those in anxiety attacks in patients with anxiety neurosis. J Clin Invest. 1940;19(5):789.
9.
PittsFNMcClureJN. Lactate metabolism in anxiety neurosis. N Engl J Med. 1967;277(25):1329–1336.
10.
AkiskalHSMallyaG.Criteria for the “soft” bipolar spectrum: Treatment implications. Psychopharmacol Bull. 1987;23(1):68–73.
11.
KraepelinE. Psychiatrie: Ein Lehrbuch für Studierende und Aerzte. 6th ed.Vol 2. Leipzig (DE): Barth; 1899.
12.
LeonhardK. Aufteilung der Endogenen Psychosen. Berlin (DE): Akademie-Verlag; 1957.
13.
HealyD. Mania: A short history of bipolar disorder. Baltimore (MA): Johns Hopkins University Press; 2008.
14.
ShorterE.Bipolar disorder in historical perspective. In: ParkerG, editor. Bipolar II disorder: Modeling, measuring and managing. Cambridge (GB): Cambridge University Press; 2008. p 5–14.
15.
Lopez-IborJJ. La angustia vital. Madrid (ES): Montalvo; 1950.
16.
ShorterE. Before Prozac: The troubled history of mood disorders in psychiatry. New York (NY): Oxford University Press; 2008.
17.
RümkeHC. Psychiatrie I, de psychosem. Amsterdam (NL): Seheltema en Holkema; 1960.
18.
CloningerCA. The discovery of susceptibility genes for mental disorders. Proc Natl Acad Sci USA. 2002;99:13365–13367.
19.
HarrisonPJOwenMJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet. 2003;361:417–419.
20.
StraubREWeinbergerDR. Schizophrenia genes—famine to feast. Biol Psychiatry. 2006;60:81–83.
21.
CraddockNOwenMJ. Rethinking psychosis: The disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry. 2007;6:20–27.
22.
van PraagHM. About the impossible concept of schizophrenia. Compr Psychiatry. 1976;17:481–497.
23.
van PraagHM. Nosologomania: A disorder of psychiatry. World J Biol Psychiatry. 2000;1:151–158.
24.
van PraagHM. Anxiety/aggression-driven depression. A paradigm of functionalization and verticalization of psychiatric diagnoses. Prog Neuropsychopharmacol Biol Psychiatry. 2001;12:28–39.
25.
van PraagHMDe KloetROs vanJ. Stress, the brain and depression. Cambridge (GB); Cambridge University Press; 2004.
26.
FreyhanFA. The influence of specific and non-specific factors on the clinical effects of psychotropic drugs. Neuropsychopharmacology. 1961;2:189–203.
27.
van PraagHM. Over the mainstream: Diagnostic requirements for biological psychiatric research. Psychiatr Res.1997;72:201–212.
28.
van PraagHMde KloetRvan OsJ. Stress, the brain, and depression. Cambridge (GB): Cambridge University Press; 2004.